5.500
−4,35%
2026-10-19
Fundamental Analysis
31 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -18.7% | -8.7% | 1 / 3 | -7.6% | +1.29 pp | -0.23 pp | +6.5% | 1.28 | 5.66 | 516 | −7,6% | 8,8 | −18,7% | 5.66 | 11.88 | −52,4% |
| Pts | 0 | 0 | 4 | 0 | 8 | 4 | 0 | 6 | 12 | |||||||
Valuation annotation:Price: 5.500 (close price on 2026-10-19)EPS (TTM): 972,3
Financial charts
1.Revenue & growth
VND bn516Q2/26
1.Revenue & growth
VND bn516Q2/26
2.Profit & growth
VND bn8,83Q2/26
3.Profit mix (Penman)
VND bn50,4Q2/26
4.Margins & cost structure
%4.4%Q2/26
5.Returns & cash cycle
% · days5.3%Q2/26
6.Earnings quality & cash
VND bn-83,6Q2/26
7.Asset structure
VND bn2.845Q2/26
8.Funding & debt health
VND bn · times2.845Q2/26
9.Revenue backlog
VND bn934Q2/26
10.Valuation
times · %5,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %215Q2/26
Adjusted EPS growth, latest quarter
-18.7%
Average adjusted EPS growth, 3 quarters
-8.0%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26